Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma
Condition: Metastatic Uveal Melanoma Interventions: Drug: Nivolumab; Drug: Relatlimab Sponsors: Jose Lutzky, MD; Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials